Changing bacterial ecology during a five year period of selective intestinal decontamination

Journal of Hospital Infection

Volumn 39, Issue 3, 1998, Pages 195-206

  Lingnau, W ^a   Berger, J ^a   Javorsky, F ^a   Fille, M ^a   Allerberger, F ^a   Benzer, H ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Acinetobacter; Bacterial resistance; Ciprofloxacin; Colonization; Gastrointestinal; Methicillin resistant staphylococci; Mortality; Nosocomial infection; Pneumonia; Selective decontamination

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; CIPROFLOXACIN; COLISTIN; OXACILLIN; TOBRAMYCIN;

ACINETOBACTER CALCOACETICUS; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECOLOGY; ENTEROBACTERIACEAE; FEMALE; GASTROINTESTINAL TRACT; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS;

EID: 0031878768     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(98)90258-4     Document Type: Article

References (40)

1. Van der Waaij D, Berghuis-de Vries JM, Lekkerkerk-van der Wees JEC. Colonization resistance of the digestive tract of conventional and antibiotic-treated mice. J Hyg Camb 1971; 69: 405-409.
2. Sleijfer DT, Mulder NH, De Vries Hospers HG et al. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 1980; 16: 859-869.
3. Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF. A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract. Acta Anaesthesiol Belg 1983; 34: 209-221.
4. Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF. The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med 1984; 10: 185-192.
5. Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF, Langrehr D. The effect of oropharyngeal decontamination using topical nonabsorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients. J Trauma 1987; 27: 357-364.
6. Mackie DP, van Hertum WA, Schumburg T, Kuijper EC, Knape P. Prevention of infection in burns: preliminary experience with selective decontamination of the digestive tract in patients with extensive injuries. J Trauma 1992; 32: 570-575.
7. Unertl K, Ruckdeschel G, Selbmann HK et al. Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med 1987; 13: 106-113.
8. Hammond JMJ, Potgieter PD, Saunders GL, Forder AA. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 1992; 340: 5-9.
9. Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group of Selective Decontamination of the Digestive Tract. N Engl J Med 1992; 326: 594-599.
10. Rocha LA, Martin MJ et al. Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. A randomized, double blind, placebo-controlled study. Intensive Care Med 1992; 18: 398-404.
11. Ulrich C, Harinck de Weerd JE, Bakker NC, Jacz K, Doornbos L, de Ridder VA. Selective decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired infections: a prospective randomized study. Intensive Care Med 1989; 15: 424-431.
12. Vandenbroucke Grauls CM, Vandenbroucke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 1991; 338: 859-862.
13. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. BMJ 1993; 307: 525-532.
14. Kollef MH. The role of selective digestive tract decontamination on mortality and respiratory tract infections. A meta-analysis. Chest 1994; 105: 1101-1108.
15. Armstrong PJ, Barr JG, Webb CH, Blair PH, Rowlands BJ. Epidemiology of Pseudomonas aeruginosa in an intensive care unit using selective decontamination of the digestive tract. J Hasp Infect 1992; 20: 199-208.
16. Nardi G, Valentinis U, Proietti A et al. Epidemiological impact of prolonged systematic use of topical SDD on bacterial colonization of the tracheobronchial tree and antibiotic resistance. A three year study. Intensive Care Med 1993; 19: 273-278.
17. Bartlett JG. Selective decontamination of the digestive tract and its effect on antimicrobial resistance. Crit Care Med 1995; 23: 613-615.
18. De Champs C, Rouby D, Guelon D et al. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase. J Hosp Infect 1991; 18: 5-13.
19. Neu HC. The crisis in antibiotic resistance. Science 1992; 257: 1064-1073.
20. Webb CH. Antibiotic resistance associated with selective decontamination of the digestive tract. J Hosp Infect 1992; 22: 1-5.
21. Konrad F, Heeg K, Graf B, Deller A, Kilian J, Ahnefeld FW. Pneumonia prevention in long-term mechanically ventilated patients: selective skin decontamination according to Stoutenbeek or prevention of colonization according to Unertl? A prospective randomized comparison of both treatments. Anasthesiol Intensivmed Notfallmed Schmerzther 1991; 26: 270-275.
22. Baker SP, O'Neill B, Haddon W, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14: 187-196.
23. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure an guidelines for the use of innovative therapies in sepsis. The ACCP/ SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
24. van Saene HK, Stoutenbeek CP, Miranda DR, Zandstra DF. A novel approach to infection control in the intensive care unit. Acta Anaesthesiol Belg 1983; 34: 193-208.
25. Acar JF, Goldstein FW. Disk susceptibility test. In: Lorian V. Ed. Antibiotics in laboratory medicine, 3rd edn. Baltimore, MD: Williams & Wilkins 1991; 17-42.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Ass 1958; 53: 457-481.
27. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
28. Johanson WG, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with Gram negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 1972; 77: 701-706.
29. Alexander JW, Boyce ST, Babcock GF et al. The process of microbial translocation. Ann Surg 1990; 212: 496-510.
30. Niederman MS, Fein AM. Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia. A common clinical sequence. Clin Chest Med 1990; 11: 633-656.
31. Brun Buisson C, Legrand P, Rauss A et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 1989; 110: 873-881.
32. Jacoby GA, Archer GL. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 1991; 324: 601-612.
33. Ismaeel NA. Colonization of intensive care unit patients by Pseudomonas aeruginosa. J Hosp Infect 1993; 25: 279-286.
34. Rozenberg Arska M, Dekker AW, Verhoef J. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. J Infect Dis 1985; 152: 104-107.
35. Saunders GL, Hammond JM, Potgieter PD, Plumb HA, Forder AA. Microbiological surveillance during selective decontamination of the digestive tract (SDD). J Antimicrob Chemother 1994; 34: 529-544.
36. Buisson Y, Tran Van Nhieu G, Ginot L et al. Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage. J Hosp Infect 1990; 15: 83-93.
37. Neu HC. Bacterial resistance to fluoroquinolones. Rev Infect Dis 1988; 10 Suppl. 1: S57-S63.
38. Muller Serieys C, Lesquoy JB, Perez E et al. Nosocomial infections caused by Acinetobacter. Epidemiology and therapeutic difficulties. Presse Med 1989; 18: 107-110.
39. Getchell White SI, Donowitz LG, Groschel DH. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus. Infect Control Hosp Epidemiol 1989; 10: 402-407.
40. Musa EK, Desai N, Casewell MW. The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica. J Hosp Infect 1990; 15: 219-227.